Digital PCR (dPCR) and Real-Time PCR (qPCR) Market
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market - Global Industry Assessment & Forecast
Segments Covered
- By Product & Service qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, dPCR Software & Services
- By Application qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications
- By End User qPCR End Users, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, Forensic Laboratories
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 5805.67 Million |
Revenue 2030: | USD 11315.90 Million |
Revenue CAGR (2023 - 2030): | 8.70% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Research Methodology: Digital PCR (dPCR) and Real-Time PCR (qPCR) Market by Product & Service by Application by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The next stage involves the primary research conducted to gather further information and revalidate the data collected from the secondary research. Moreover, primary research is also conducted to identify key players in the market and to gather their market-specific financial information. A typical primary interview fulfills data requirements pertaining to first-hand information global market size, regional and segmental trends, competitive landscape expertise development and market understandings among others.
Data Triangulation and Market Size Estimations
Top-down and bottom-up approaches are used to validate and estimate the market size of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. The data was triangulated by employing various data models and statistical techniques to arrive at exact statics and market size for each segment/sub-segment of the market.
FAQ
Frequently Asked Question
What is the global demand for Digital PCR (dPCR) and Real-Time PCR (qPCR) in terms of revenue?
-
The global Digital PCR (dPCR) and Real-Time PCR (qPCR) valued at USD 5805.67 Million in 2022 and is expected to reach USD 11315.90 Million in 2030 growing at a CAGR of 8.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (German), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), Quidel Corporation (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Digital PCR (dPCR) and Real-Time PCR (qPCR) include
- Growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to genome-based drugs.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Digital PCR (dPCR) and Real-Time PCR (qPCR) in 2022.